US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.6300
  • +0.2300+9.58%
Close Mar 4 16:00 ET
  • 2.6400
  • +0.0100+0.38%
Post 20:01 ET
7.13MMarket Cap-1.23P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
86.47%-5.49M
301.77%14.21M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
Net income from continuing operations
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
Depreciation and amortization
----
----
----
--0
----
----
----
----
-86.23%65K
--0
Change In working capital
65.28%-768K
101.16%32K
-262.42%-510K
-61.44%-4.6M
105.26%50K
-104.63%-2.21M
-422.37%-2.75M
118.78%314K
-302.41%-2.85M
-130.54%-951K
-Change in receivables
---44K
----
----
2,300.00%96K
--0
--0
----
----
-85.19%4K
125.86%131K
-Change in prepaid assets
-258.81%-505K
140.25%192K
-43.70%134K
195.12%363K
205.58%284K
186.49%318K
-232.50%-477K
401.27%238K
209.82%123K
26.50%-269K
-Change in payables and accrued expense
91.60%-219K
93.81%-160K
-570.83%-644K
-60.24%-5.54M
71.73%-255K
-96.98%-2.61M
-815.79%-2.58M
93.98%-96K
-449.29%-3.46M
-127.38%-902K
-Change in other current assets
--0
--0
--0
0.00%481K
-76.40%21K
-41.98%76K
59.40%212K
34.38%172K
-68.99%481K
-30.47%89K
Cash from discontinued investing activities
-15.75M
0
Operating cash flow
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.21%-40.61M
18.39%-7.04M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
----
----
--10.4M
--0
--10.4M
----
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
0
17,224.14%5.02M
0
0
-99.91%29K
-85.88%12K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
----
----
17,224.14%5.02M
41,566.67%5M
--0
----
----
-89.72%29K
-85.88%12K
Cash from discontinued financing activities
Financing cash flow
--0
----
----
17,224.14%5.02M
--0
--0
----
----
-99.91%29K
-85.88%12K
Net cash flow
Beginning cash position
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-75.20%13.38M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-7.33%53.96M
-67.35%20.41M
Current changes in cash
-149.50%-1.72M
27.76%-1.11M
69.89%-1.87M
85.66%-5.82M
78.08%-1.54M
134.97%3.47M
85.83%-1.53M
51.59%-6.21M
-849.29%-40.58M
17.72%-7.03M
Effect of exchange rate changes
--0
-166.67%-2K
-500.00%-4K
166.67%8K
-50.00%4K
--0
400.00%3K
200.00%1K
-25.00%3K
166.67%8K
End cash Position
-68.47%2.87M
-18.67%4.59M
-20.55%5.7M
-43.42%7.57M
-43.42%7.57M
-55.36%9.11M
-81.40%5.64M
-82.57%7.17M
-75.20%13.38M
-75.20%13.38M
Free cash flow
75.26%-1.72M
83.13%-1.11M
69.89%-1.87M
47.69%-21.25M
78.12%-1.54M
30.06%-6.94M
39.41%-6.56M
51.59%-6.21M
-11.19%-40.61M
18.39%-7.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 75.26%-1.72M83.13%-1.11M69.89%-1.87M86.47%-5.49M301.77%14.21M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M
Net income from continuing operations -109.56%-723K68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M
Depreciation and amortization --------------0-----------------86.23%65K--0
Change In working capital 65.28%-768K101.16%32K-262.42%-510K-61.44%-4.6M105.26%50K-104.63%-2.21M-422.37%-2.75M118.78%314K-302.41%-2.85M-130.54%-951K
-Change in receivables ---44K--------2,300.00%96K--0--0---------85.19%4K125.86%131K
-Change in prepaid assets -258.81%-505K140.25%192K-43.70%134K195.12%363K205.58%284K186.49%318K-232.50%-477K401.27%238K209.82%123K26.50%-269K
-Change in payables and accrued expense 91.60%-219K93.81%-160K-570.83%-644K-60.24%-5.54M71.73%-255K-96.98%-2.61M-815.79%-2.58M93.98%-96K-449.29%-3.46M-127.38%-902K
-Change in other current assets --0--0--00.00%481K-76.40%21K-41.98%76K59.40%212K34.38%172K-68.99%481K-30.47%89K
Cash from discontinued investing activities -15.75M0
Operating cash flow 75.26%-1.72M83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.21%-40.61M18.39%-7.04M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0----------10.4M--0--10.4M----------0--0
Financing cash flow
Cash flow from continuing financing activities 017,224.14%5.02M00-99.91%29K-85.88%12K
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees --0--------17,224.14%5.02M41,566.67%5M--0---------89.72%29K-85.88%12K
Cash from discontinued financing activities
Financing cash flow --0--------17,224.14%5.02M--0--0---------99.91%29K-85.88%12K
Net cash flow
Beginning cash position -18.67%4.59M-20.55%5.7M-43.42%7.57M-75.20%13.38M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-7.33%53.96M-67.35%20.41M
Current changes in cash -149.50%-1.72M27.76%-1.11M69.89%-1.87M85.66%-5.82M78.08%-1.54M134.97%3.47M85.83%-1.53M51.59%-6.21M-849.29%-40.58M17.72%-7.03M
Effect of exchange rate changes --0-166.67%-2K-500.00%-4K166.67%8K-50.00%4K--0400.00%3K200.00%1K-25.00%3K166.67%8K
End cash Position -68.47%2.87M-18.67%4.59M-20.55%5.7M-43.42%7.57M-43.42%7.57M-55.36%9.11M-81.40%5.64M-82.57%7.17M-75.20%13.38M-75.20%13.38M
Free cash flow 75.26%-1.72M83.13%-1.11M69.89%-1.87M47.69%-21.25M78.12%-1.54M30.06%-6.94M39.41%-6.56M51.59%-6.21M-11.19%-40.61M18.39%-7.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LEETRO
430425
+29.97%
Geovis Insighter Technology
920116
+23.98%
Beijing Global Safety Technology
300523
+20.01%
4
Zhejiang JW Precision Machinery
300984
+20.00%
5
Wintao Communications
301139
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025